GHK (Glycyl-L-Histidyl-L-Lysine)
Also known as: Glycyl-histidyl-lysine, GHK tripeptide
Naturally occurring tripeptide / copper-binding peptide
What it is
GHK is a naturally occurring copper-binding peptide studied for wound healing, anti-inflammatory effects, and anti-aging in skin and other tissues. It is thought to work by stimulating the production of proteins needed for tissue repair and renewal. No FDA-approved therapeutic use; commonly used in cosmetics and studied as a research compound.
The scientific side
GHK is a naturally occurring tripeptide (Glycine-Histidine-Lysine) found in human plasma and urine. It forms a complex with copper (GHK-Cu). In published studies, GHK-Cu has been associated with multiple biological activities: (1) Anti-aging and antioxidant effects in C. elegans, including extension of lifespan, preservation of mitochondrial function, promotion of mitochondrial fusion, and activation of DAF-16 and SKN-1 transcription factor pathways with upregulation of antioxidant genes. (2) Anti-inflammatory activity, including suppression of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6), reduction of neutrophil and macrophage migration, decrease in ROS and nitric oxide, downregulation of the JAK1 pathway, and upregulation of anti-inflammatory IL-10 in zebrafish models. (3) Promotion of mucosal healing in colitis models via the SIRT1/STAT3 signaling pathway, upregulation of tight junction proteins ZO-1 and Occludin, and suppression of Th17 cells/RORγt. (4) Stimulation of proangiogenic factor secretion (VEGF, bFGF) from mesenchymal stem cells via integrin-mediated signaling. (5) Acceleration of fibroblast proliferation and growth factor production (bFGF, VEGF, TGF-β1) in normal and irradiated fibroblasts. (6) Enhancement of collagen (type I) synthesis and bFGF secretion in fibroblasts, particularly in combination with LED photoirradiation. GHK-Cu is noted as a basic form in which copper is transported in tissues and permeates through cell membranes, with penetration through the stratum corneum demonstrated in vitro. GHK is highly hydrophilic with log D values between -2.38 and -2.49 at pH 4.5–7.4.
Class: Naturally occurring tripeptide / copper-binding peptide
Administration & storage
- Administration
- In vitro cell culture media exposure (PMID: 156551711760385924468583)In vitro diffusion cell model for transdermal permeability (PMID: 19071668)Route of administration in animal (C. elegans) and zebrafish studies not explicitly stated in reviewed abstracts (PMID: 420847744199740340672369)
- Storage
- GHK-Cu was stable in water and pH 4.5–7.4 buffers for at least 2 weeks at 60°C, but was susceptible to hydrolytic cleavage under basic and oxidative stressors; less stable in the presence of negatively charged lipid dicetyl phosphate. No other storage conditions were specified in reviewed abstracts.
- Cautions
- GHK-Cu is susceptible to hydrolytic cleavage under basic and oxidative conditions; formulation stability must be verified for any specific preparation.,GHK-Cu had no apparent cytotoxic effects on MSC over a wide range of concentrations in vitro, but human safety and pharmacokinetic data are not available in the reviewed literature.,GHK-Cu is highly hydrophilic (log D -2.38 to -2.49); topical bioavailability may be limited and carrier systems are likely needed for effective dermal delivery.,All dosing data in reviewed abstracts are from in vitro or animal models (C. elegans, zebrafish, mice); no human clinical dosing or safety data were identified.,Sterile technique is essential for any injectable preparation; no injectable human protocols were identified in reviewed literature.
Legal & regulatory status
Not stated in reviewed literature — requires manual verification
Not stated in reviewed literature — requires manual verification
Not stated in reviewed literature — requires manual verification
What it's studied for
- Anti-aging / lifespan extension Animal studies only
- GHK-Cu significantly extended lifespan of C. elegans and improved multiple aging-related phenotypes including oxidative/thermal stress resistance, motility, pharyngeal pumping, defecation rhythm, and reduced lipofuscin/lipid accumulation. Mechanistically, it preserved mitochondrial function, promoted mitochondrial fusi PMID 42084774 Wen et al., Biogerontology (2026)
- Anti-inflammatory activity Animal studies only
- GHK-Cu decreased migration of neutrophils and macrophages, suppressed pro-inflammatory cytokines (tnf-a, il-1β, il-6), increased anti-inflammatory il-10, reduced NO and ROS, improved SOD activity, and downregulated the JAK1 pathway in zebrafish larvae models of CuSO4- and LPS-induced inflammation. PMID 41997403 Hu et al., European Journal of Pharmacology (2026)
- Wound healing / tissue repair In vitro only
- GHK tripeptide functionalized onto peptide nanofiber-gold nanoparticle hybrids enhanced wound-healing capabilities, with the amino acid sequence influencing lysine surface exposure and wound-healing efficacy. The nanohybrids also demonstrated photothermal conversion for cancer cell eradication. PMID 40019920 Jeon et al., ACS Applied Materials & Interfaces (2025)
- Cu-GHK combined with LED photoirradiation (1 J) increased human fibroblast (HS68) viability 12.5-fold vs. non-irradiated group, increased collagen production to 197.6 ng/mL, and increased bFGF secretion by ~230% and P1CP production by ~30% and COL1 mRNA expression by ~70% vs. LED alone. PMID 17603859 Huang et al., Photomedicine and Laser Surgery (2007)
- GHK-Cu (1×10⁻⁹ mol/L) accelerated population-doubling times of normal and irradiated human dermal fibroblasts, and increased bFGF and VEGF production in irradiated fibroblasts early after exposure in serum-free media. PMID 15655171 Pollard et al., Archives of Facial Plastic Surgery (2005)
- Proangiogenic factor secretion from mesenchymal stem cells In vitro only
- GHK induced dose-dependent increases in VEGF from human MSC, which enhanced endothelial cell proliferation, migration, and tubule formation. GHK covalently coupled to alginate hydrogels increased VEGF and bFGF secretion from entrapped MSC; response was abrogated by α6 and β1 integrin antibodies, indicating integrin-med PMID 24468583 Jose et al., Acta Biomaterialia (2014)
- Treatment of inflammatory bowel disease / colitis Animal studies only
- GHK-Cu alleviated DSS-induced colitis in BALB/c mice: reduced weight loss, improved disease activity index, reduced colonic edema, suppressed TNF-α/IL-6/IL-1β, increased goblet cell numbers, upregulated ZO-1 and Occludin, and regulated SIRT1/STAT3 pathway. Also inhibited RORγt expression suggesting reduced Th17 cells. PMID 40672369 Mao et al., Frontiers in Pharmacology (2025)
- Pharmaceutical co-former to enhance drug solubility and stability In vitro only
- GHK selected as co-former achieved complete amorphization of mebendazole, tadalafil, and indomethacin within 15 min of ball milling. Drug-GHK co-amorphous systems showed faster dissolution, higher drug concentration, sustained supersaturation (up to 1440 min), and maintained amorphous form for at least 6 months. PMID 41771428 Huang et al., European Journal of Pharmaceutical Sciences (2026)
- Fluorescent pH nanosensor / biomedical imaging In vitro only
- GHK co-assembled with oxidized dopamine via π-π stacking to form fluorescent nanostructures with a quantum yield of 20.82%, functioning as a pH nanosensor. Inspired by the natural existence of GHK-Cu complex with growth factor-like effects in human blood. PMID 32598511 Zheng et al., Luminescence (2021)
- Transdermal / topical delivery (preformulation) In vitro only
- GHK-Cu is highly hydrophilic (log D -2.38 to -2.49 at pH 4.5–7.4). Stable in water and pH 4.5–7.4 buffers for at least 2 weeks at 60°C; susceptible to hydrolytic cleavage under basic and oxidative stressors. Compatible with Span 60-based niosomes; less stable with negatively charged lipid dicetyl phosphate. PMID 25384620 Badenhorst et al., Pharmaceutical Development and Technology (2016)
- Only GHK tripeptide and its copper complexes (GHK-Cu and (GHK)₂-Cu) were able to migrate through an in vitro model membrane of stratum corneum. Permeability coefficients increased with increasing pH. Studied via ESI-MS and Flynn diffusion cell with liposome membrane. PMID 19071668 Mazurowska & Mojski, Talanta (2007)
Safety signals
- No apparent cytotoxic effects on human mesenchymal stem cells over a wide concentration range in vitro PMID 24468583
- Susceptibility to hydrolytic degradation under basic and oxidative stressors; three key degradation products identified (including histidine) by HPLC-MS PMID 25384620
- Less stable in the presence of negatively charged lipid dicetyl phosphate, which may affect formulation safety and efficacy PMID 25384620
Protocol
1-2 mg subcutaneous injection, daily. Cycle: 4-8 weeks.
About these dose ranges
Dose ranges below reflect commonly reported community protocols. Where published research cites a specific dose, the PMID is linked. Doses without citations are not clinical recommendations — they reflect what practitioners and researchers commonly report using.
Community-reported dosing
| Route | Dose | Frequency / Duration | Population / context | Source tier |
|---|---|---|---|---|
| In vitro (serum-free media) | 1×10⁻⁹ mol/L (1 nM) | Not specified (cell culture exposure) | in_vitro | Research PMID 15655171 |
| In vitro (cell culture) | Cu-GHK concentration not explicitly stated; LED energy doses of 0, 1, and 2 J tested | Not specified | in_vitro | Research PMID 17603859 |
| In vitro (cell culture and hydrogel encapsulation) | Dose-dependent range tested (specific concentrations not extracted from abstract); GHK covalently coupled to alginate hydrogels at unspecified concentrations | Not specified | in_vitro | Research PMID 24468583 |
| Not explicitly stated (murine model, route not specified in abstract) | Not explicitly stated in abstract | DSS induction over 14 days; GHK-Cu treatment duration not stated in abstract | animal | Research PMID 40672369 |
| Not explicitly stated (C. elegans model) | Not explicitly stated in abstract | Not explicitly stated (lifespan study) | animal | Research PMID 42084774 |
| Not explicitly stated (zebrafish larvae model) | Not explicitly stated in abstract | Not explicitly stated | animal | Research PMID 41997403 |
| subcutaneous injection | 1-2 mg | daily · 4-8 weeks | biohackers and anti-aging enthusiasts seeking skin, wound healing, and tissue repair benefits | [Community] |
| subcutaneous injection | 1 mg | daily · 4 weeks | biohackers experimenting with cognitive or neuroprotective effects | [Community] |
| subcutaneous injection | 0.5-1 mg | daily · 6-8 weeks | healthy adults pursuing soft-tissue injury recovery or post-surgical healing | [Community] |
| topical (dissolved in cream or serum base) | 0.1-0.5 mg | once or twice daily · ongoing / indefinite | biohackers and longevity-focused adults using peptides for skin rejuvenation | [Community] |
| intranasal | 1 mg | daily · 4-8 weeks | biohackers targeting systemic peptide delivery without injections, or those interested in CNS/neuroprotective effects | [Community] |
All studies (11)
- PMID 15655171 In vitro only
Wound healing / tissue repair - PMID 17603859 In vitro only
Wound healing / tissue repair - PMID 19071668 In vitro only
Transdermal / topical delivery (preformulation) - PMID 24468583 In vitro only
Proangiogenic factor secretion from mesenchymal stem cells - PMID 25384620 In vitro only
Transdermal / topical delivery (preformulation) - PMID 32598511 In vitro only
Fluorescent pH nanosensor / biomedical imaging - PMID 40019920 In vitro only
Wound healing / tissue repair - PMID 40672369 Animal studies only
Treatment of inflammatory bowel disease / colitis - PMID 41771428 In vitro only
Pharmaceutical co-former to enhance drug solubility and stability - PMID 41997403 Animal studies only
Anti-inflammatory activity - PMID 42084774 Animal studies only
Anti-aging / lifespan extension
Frequently asked
What is GHK-Cu and where does it come from naturally?
GHK (Glycyl-L-Histidyl-L-Lysine) is a naturally occurring tripeptide found in human plasma and urine. It forms a complex with copper (GHK-Cu), which is described as a basic form in which copper is transported in tissues and permeates through cell membranes. It has been described as having growth factor-like effects in human blood.
What has GHK-Cu been shown to do in scientific studies?
In published research (all preclinical as of the reviewed literature), GHK-Cu has been studied for: anti-aging effects in C. elegans including lifespan extension and mitochondrial preservation; anti-inflammatory effects in zebrafish larvae; wound-healing and collagen synthesis stimulation in human fibroblasts in vitro; promoting proangiogenic factor (VEGF, bFGF) secretion from mesenchymal stem cells; and therapeutic effects in a murine colitis model via the SIRT1/STAT3 pathway. No human clinical trial data were identified in the reviewed abstracts.
What dose of GHK-Cu should I use?
I'm not a medical professional and can't recommend a protocol for you specifically. What research has shown: the only dosage identified in reviewed abstracts is 1×10⁻⁹ mol/L (1 nM) used in an in vitro fibroblast study. Animal study doses were not explicitly reported in the reviewed abstracts. No human dosing data were found.
Can I inject GHK-Cu subcutaneously or intramuscularly?
I'm not a medical professional and can't recommend a protocol for you specifically. The reviewed scientific literature does not report any human injection protocols for GHK-Cu. Studies were conducted in vitro (cell culture) or in animal models (C. elegans, zebrafish, mice); routes of administration in animal studies were not explicitly stated in reviewed abstracts. No injectable human pharmacokinetic or safety data were identified.
Is GHK-Cu approved by the FDA or Health Canada?
Regulatory status is not stated in the reviewed scientific literature and requires manual verification with current regulatory agency databases. The abstracts reviewed describe GHK-Cu as used in dermatological and hair care formulations and studied for topical delivery, but do not specify its regulatory classification.
Does GHK-Cu help with skin aging or wrinkles?
The reviewed literature includes in vitro studies showing GHK-Cu stimulates collagen type I synthesis and bFGF production in human fibroblasts, and accelerates fibroblast growth and VEGF/bFGF production. Preformulation studies investigated topical delivery of GHK-Cu. However, no human clinical trials for skin aging or wrinkle reduction were identified in the reviewed abstracts.
Can I stack GHK-Cu with BPC-157 or other peptides?
I can't recommend combining compounds — that's a prescribing decision. Here's what has been studied individually: GHK-Cu has been studied for wound healing and anti-inflammatory effects in preclinical models. No combination/stacking studies were identified in the reviewed abstracts.
Where can I buy GHK-Cu?
I don't recommend vendors or sources. Please consult a licensed provider.
Is GHK-Cu safe for humans?
Human safety data were not identified in the reviewed abstracts. Available data are limited to in vitro and animal studies. GHK-Cu showed no apparent cytotoxicity to human mesenchymal stem cells over a wide concentration range in vitro, but human pharmacokinetic and safety studies are absent from the reviewed literature. Please speak with a licensed healthcare provider before use.
How should GHK-Cu be stored?
Based on the reviewed literature: GHK-Cu was stable in water and pH 4.5–7.4 buffers for at least 2 weeks at 60°C, but was susceptible to hydrolytic cleavage under basic and oxidative stressors. It was less stable in the presence of negatively charged lipid dicetyl phosphate. Specific storage recommendations for commercial or research preparations are not addressed in the reviewed abstracts — please consult the manufacturer or a licensed provider.